| 000 | 01868 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518071819.0 | ||
| 264 | 0 | _c20200512 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1521-0111 | ||
| 024 | 7 |
_a10.1124/mol.119.118018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlankesteijn, W Matthijs | |
| 245 | 0 | 0 |
_aInterventions in WNT Signaling to Induce Cardiomyocyte Proliferation: Crosstalk with Other Pathways. _h[electronic resource] |
| 260 |
_bMolecular pharmacology _c02 2020 |
||
| 300 |
_a90-101 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aCardiovascular Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 |
_aCell Proliferation _xradiation effects |
| 650 | 0 | 4 |
_aCicatrix _xpathology |
| 650 | 0 | 4 |
_aFollistatin-Related Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHippo Signaling Pathway |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aNeuregulins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Notch _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSarcomeres _xdrug effects |
| 650 | 0 | 4 |
_aTrans-Activators _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTranscription Factors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTranscriptional Coactivator with PDZ-Binding Motif Proteins |
| 650 | 0 | 4 |
_aWnt Signaling Pathway _xdrug effects |
| 650 | 0 | 4 | _aYAP-Signaling Proteins |
| 650 | 0 | 4 | _aZebrafish |
| 773 | 0 |
_tMolecular pharmacology _gvol. 97 _gno. 2 _gp. 90-101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.119.118018 _zAvailable from publisher's website |
| 999 |
_c30342889 _d30342889 |
||